Biomarkers and Molecular Mechanisms in Renal Diseases

Biomarkers and Molecular Mechanisms in Renal Diseases are pivotal for understanding kidney pathophysiology and improving diagnosis and treatment. Biomarkers such as albuminuria, creatinine levels, and novel markers like kidney injury molecule-1 (KIM-1) help detect early kidney damage, assess disease progression, and predict patient outcomes. Understanding the molecular mechanisms, including inflammatory pathways, fibrosis, and genetic factors, aids in the development of targeted therapies for conditions like glomerulonephritis, diabetic nephropathy, and acute kidney injury. Ongoing research aims to identify new biomarkers for personalized medicine and improve therapeutic approaches in nephrology.

 

    Related Conference of Biomarkers and Molecular Mechanisms in Renal Diseases

    August 27-28, 2026

    30th European Nephrology Conference

    Berlin, Germany
    September 21-22, 2026

    18th World Nephrology Summit

    Paris, France
    November 10-11, 2026

    13th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    November 16-17, 2026

    12th World Kidney Congress

    Tokyo, Japan
    March 29-30, 2027

    23rd World Nephrology Conference

    Amsterdam, Netherlands
    March 30-31, 2027

    18th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE

    Biomarkers and Molecular Mechanisms in Renal Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in